The Form 4 filing, an SEC report of insider stock activity, was filed on Oct. 29, 2026. It lists Oct. 27, 2026, as both the first and last trade date for Steven E. Cunningham, chief executive officer of Enova International, Inc. (ENVA).
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-10-27 |
| Date of Latest Transaction | 2026-10-27 |
| Buy/Sell | sell |
| Transaction Count | 2 |
| Shares Transacted | 11,149 |
| Price | $172.00 |
| Total Transaction Value | $1,917,628.00 |
| Insider | |
| Ticker Symbol | ENVA |
| Company | Enova International, Inc. |
| Insider Name | Cunningham Steven E |
| Insider Title | Chief Executive Officer |
| Sector - Industry | Other - Unclassified |
| Holdings | |
| Total Shares Owned After Transaction | 122,945 |
| Position Size Change | 8.31% |
| Filing | |
| Filing Date | 2026-10-29 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a sale of shares under transaction code S. The sale also has a possible link to an exercise or conversion. An exercise uses a right to buy shares. A conversion exchanges another investment for shares.
What was the average price of the transaction?
The average sale price was $172.00 per share across the two reported transactions.
How did this transaction affect the insider's holdings?
Steven E. Cunningham sold 11,149 shares and reported 122,945 shares owned afterward. The shares sold made up 8.31% of his reported shares owned before the sale.
What's the total transaction value?
The two sale transactions had a total value of $1,917,628.00. That amount covers all 11,149 shares sold. The cost of any related exercise or conversion is unknown.
Are there any special circumstances around this transaction?
Yes. A match in share counts suggests a link to a code M exercise or conversion in the same filing. The related transaction details and filing footnotes are unavailable here. That match does not confirm that the dates, share types, or accounts were the same. It also does not show whether the exact shares received were sold or whether the sale was required.
For research purposes only; not investment advice.